nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—Bradyphrenia—Varenicline—nicotine dependence	0.0874	0.118	CcSEcCtD
Clonidine—Emotional disorder—Varenicline—nicotine dependence	0.0542	0.0733	CcSEcCtD
Clonidine—Rash generalised—Varenicline—nicotine dependence	0.0278	0.0377	CcSEcCtD
Clonidine—NISCH—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.0222	0.085	CbGpPWpGaD
Clonidine—Sleep disturbance—Varenicline—nicotine dependence	0.0211	0.0286	CcSEcCtD
Clonidine—Sexual dysfunction—Varenicline—nicotine dependence	0.0211	0.0286	CcSEcCtD
Clonidine—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.0181	0.0244	CcSEcCtD
Clonidine—Rhinorrhoea—Varenicline—nicotine dependence	0.0146	0.0198	CcSEcCtD
Clonidine—Endocrine disorder—Varenicline—nicotine dependence	0.0143	0.0193	CcSEcCtD
Clonidine—Aggression—Varenicline—nicotine dependence	0.0135	0.0182	CcSEcCtD
Clonidine—Nocturia—Varenicline—nicotine dependence	0.0128	0.0173	CcSEcCtD
Clonidine—Abnormal dreams—Varenicline—nicotine dependence	0.0117	0.0158	CcSEcCtD
Clonidine—Influenza like illness—Varenicline—nicotine dependence	0.0115	0.0155	CcSEcCtD
Clonidine—Nightmare—Varenicline—nicotine dependence	0.0114	0.0155	CcSEcCtD
Clonidine—Dry eye—Varenicline—nicotine dependence	0.0109	0.0148	CcSEcCtD
Clonidine—Sleep disorder—Varenicline—nicotine dependence	0.00992	0.0134	CcSEcCtD
Clonidine—Libido decreased—Varenicline—nicotine dependence	0.00926	0.0125	CcSEcCtD
Clonidine—Thirst—Varenicline—nicotine dependence	0.00902	0.0122	CcSEcCtD
Clonidine—Lethargy—Varenicline—nicotine dependence	0.00876	0.0119	CcSEcCtD
Clonidine—Cerebrovascular accident—Varenicline—nicotine dependence	0.00876	0.0119	CcSEcCtD
Clonidine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00861	0.033	CbGpPWpGaD
Clonidine—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00852	0.0115	CcSEcCtD
Clonidine—Irritability—Varenicline—nicotine dependence	0.0082	0.0111	CcSEcCtD
Clonidine—Urinary retention—Varenicline—nicotine dependence	0.00817	0.0111	CcSEcCtD
Clonidine—Liver function test abnormal—Varenicline—nicotine dependence	0.00793	0.0107	CcSEcCtD
Clonidine—Abdominal pain upper—Varenicline—nicotine dependence	0.00784	0.0106	CcSEcCtD
Clonidine—Breast disorder—Varenicline—nicotine dependence	0.00776	0.0105	CcSEcCtD
Clonidine—Cramp muscle—Varenicline—nicotine dependence	0.00773	0.0105	CcSEcCtD
Clonidine—Nasopharyngitis—Varenicline—nicotine dependence	0.00768	0.0104	CcSEcCtD
Clonidine—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.0075	0.0288	CbGpPWpGaD
Clonidine—Asthma—Varenicline—nicotine dependence	0.00742	0.01	CcSEcCtD
Clonidine—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.00709	0.0272	CbGpPWpGaD
Clonidine—Pollakiuria—Varenicline—nicotine dependence	0.00686	0.00928	CcSEcCtD
Clonidine—Erectile dysfunction—Varenicline—nicotine dependence	0.00684	0.00925	CcSEcCtD
Clonidine—Weight increased—Varenicline—nicotine dependence	0.00676	0.00914	CcSEcCtD
Clonidine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00672	0.0257	CbGpPWpGaD
Clonidine—Depression—Varenicline—nicotine dependence	0.0066	0.00893	CcSEcCtD
Clonidine—Epistaxis—Varenicline—nicotine dependence	0.00624	0.00845	CcSEcCtD
Clonidine—Bradycardia—Varenicline—nicotine dependence	0.00605	0.00818	CcSEcCtD
Clonidine—Hypoaesthesia—Varenicline—nicotine dependence	0.00591	0.008	CcSEcCtD
Clonidine—Hallucination—Varenicline—nicotine dependence	0.00591	0.008	CcSEcCtD
Clonidine—Eye disorder—Varenicline—nicotine dependence	0.00555	0.00751	CcSEcCtD
Clonidine—Tinnitus—Varenicline—nicotine dependence	0.00554	0.0075	CcSEcCtD
Clonidine—Cardiac disorder—Varenicline—nicotine dependence	0.00551	0.00746	CcSEcCtD
Clonidine—Angiopathy—Varenicline—nicotine dependence	0.00539	0.00729	CcSEcCtD
Clonidine—Mediastinal disorder—Varenicline—nicotine dependence	0.00535	0.00725	CcSEcCtD
Clonidine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00534	0.0204	CbGpPWpGaD
Clonidine—Arrhythmia—Varenicline—nicotine dependence	0.00531	0.00718	CcSEcCtD
Clonidine—Mental disorder—Varenicline—nicotine dependence	0.00521	0.00704	CcSEcCtD
Clonidine—Erythema—Varenicline—nicotine dependence	0.00517	0.007	CcSEcCtD
Clonidine—ADRA1D—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00506	0.0194	CbGpPWpGaD
Clonidine—Muscle spasms—Varenicline—nicotine dependence	0.00497	0.00673	CcSEcCtD
Clonidine—Vision blurred—Varenicline—nicotine dependence	0.00487	0.0066	CcSEcCtD
Clonidine—Tremor—Varenicline—nicotine dependence	0.00485	0.00656	CcSEcCtD
Clonidine—Ill-defined disorder—Varenicline—nicotine dependence	0.0048	0.00649	CcSEcCtD
Clonidine—Agitation—Varenicline—nicotine dependence	0.00475	0.00643	CcSEcCtD
Clonidine—Angioedema—Varenicline—nicotine dependence	0.00473	0.00639	CcSEcCtD
Clonidine—Malaise—Varenicline—nicotine dependence	0.00466	0.00631	CcSEcCtD
Clonidine—Syncope—Varenicline—nicotine dependence	0.00464	0.00628	CcSEcCtD
Clonidine—Palpitations—Varenicline—nicotine dependence	0.00457	0.00618	CcSEcCtD
Clonidine—Loss of consciousness—Varenicline—nicotine dependence	0.00455	0.00615	CcSEcCtD
Clonidine—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00452	0.0173	CbGpPWpGaD
Clonidine—Cough—Varenicline—nicotine dependence	0.00451	0.00611	CcSEcCtD
Clonidine—Chest pain—Varenicline—nicotine dependence	0.0044	0.00596	CcSEcCtD
Clonidine—Arthralgia—Varenicline—nicotine dependence	0.0044	0.00596	CcSEcCtD
Clonidine—Anxiety—Varenicline—nicotine dependence	0.00439	0.00594	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00437	0.00592	CcSEcCtD
Clonidine—Discomfort—Varenicline—nicotine dependence	0.00435	0.00589	CcSEcCtD
Clonidine—Dry mouth—Varenicline—nicotine dependence	0.00431	0.00583	CcSEcCtD
Clonidine—Oedema—Varenicline—nicotine dependence	0.00422	0.00571	CcSEcCtD
Clonidine—ADRA1B—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.0042	0.0161	CbGpPWpGaD
Clonidine—Infection—Varenicline—nicotine dependence	0.00419	0.00567	CcSEcCtD
Clonidine—Shock—Varenicline—nicotine dependence	0.00415	0.00562	CcSEcCtD
Clonidine—Nervous system disorder—Varenicline—nicotine dependence	0.00414	0.0056	CcSEcCtD
Clonidine—Thrombocytopenia—Varenicline—nicotine dependence	0.00413	0.00559	CcSEcCtD
Clonidine—Tachycardia—Varenicline—nicotine dependence	0.00412	0.00557	CcSEcCtD
Clonidine—Skin disorder—Varenicline—nicotine dependence	0.0041	0.00555	CcSEcCtD
Clonidine—Hyperhidrosis—Varenicline—nicotine dependence	0.00408	0.00552	CcSEcCtD
Clonidine—Anorexia—Varenicline—nicotine dependence	0.00402	0.00544	CcSEcCtD
Clonidine—Hypotension—Varenicline—nicotine dependence	0.00394	0.00534	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00385	0.0052	CcSEcCtD
Clonidine—Insomnia—Varenicline—nicotine dependence	0.00382	0.00517	CcSEcCtD
Clonidine—ADRA1D—Monoamine GPCRs—DRD2—nicotine dependence	0.00379	0.0145	CbGpPWpGaD
Clonidine—Dyspnoea—Varenicline—nicotine dependence	0.00376	0.00509	CcSEcCtD
Clonidine—Somnolence—Varenicline—nicotine dependence	0.00375	0.00508	CcSEcCtD
Clonidine—ADRA1A—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00373	0.0143	CbGpPWpGaD
Clonidine—Decreased appetite—Varenicline—nicotine dependence	0.00367	0.00497	CcSEcCtD
Clonidine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00364	0.00493	CcSEcCtD
Clonidine—Fatigue—Varenicline—nicotine dependence	0.00364	0.00492	CcSEcCtD
Clonidine—Constipation—Varenicline—nicotine dependence	0.00361	0.00488	CcSEcCtD
Clonidine—Pain—Varenicline—nicotine dependence	0.00361	0.00488	CcSEcCtD
Clonidine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00349	0.0134	CbGpPWpGaD
Clonidine—Feeling abnormal—Varenicline—nicotine dependence	0.00348	0.00471	CcSEcCtD
Clonidine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00345	0.00467	CcSEcCtD
Clonidine—ADRA2B—Monoamine GPCRs—DRD2—nicotine dependence	0.00342	0.0131	CbGpPWpGaD
Clonidine—Urticaria—Varenicline—nicotine dependence	0.00335	0.00454	CcSEcCtD
Clonidine—Abdominal pain—Varenicline—nicotine dependence	0.00334	0.00452	CcSEcCtD
Clonidine—Body temperature increased—Varenicline—nicotine dependence	0.00334	0.00452	CcSEcCtD
Clonidine—ADRA2C—Monoamine GPCRs—DRD2—nicotine dependence	0.00319	0.0122	CbGpPWpGaD
Clonidine—ADRA1D—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00318	0.0122	CbGpPWpGaD
Clonidine—ADRA1B—Monoamine GPCRs—DRD2—nicotine dependence	0.00314	0.012	CbGpPWpGaD
Clonidine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00312	0.0119	CbGpPWpGaD
Clonidine—Hypersensitivity—Varenicline—nicotine dependence	0.00311	0.00421	CcSEcCtD
Clonidine—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00308	0.0118	CbGpPWpGaD
Clonidine—Asthenia—Varenicline—nicotine dependence	0.00303	0.0041	CcSEcCtD
Clonidine—Pruritus—Varenicline—nicotine dependence	0.00299	0.00404	CcSEcCtD
Clonidine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00294	0.0113	CbGpPWpGaD
Clonidine—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00291	0.0111	CbGpPWpGaD
Clonidine—Diarrhoea—Varenicline—nicotine dependence	0.00289	0.00391	CcSEcCtD
Clonidine—ADRA2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00287	0.011	CbGpPWpGaD
Clonidine—ADRA1A—Monoamine GPCRs—DRD2—nicotine dependence	0.00279	0.0107	CbGpPWpGaD
Clonidine—Dizziness—Varenicline—nicotine dependence	0.00279	0.00378	CcSEcCtD
Clonidine—ADRA2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00269	0.0103	CbGpPWpGaD
Clonidine—Vomiting—Varenicline—nicotine dependence	0.00268	0.00363	CcSEcCtD
Clonidine—Rash—Varenicline—nicotine dependence	0.00266	0.0036	CcSEcCtD
Clonidine—Dermatitis—Varenicline—nicotine dependence	0.00266	0.0036	CcSEcCtD
Clonidine—Headache—Varenicline—nicotine dependence	0.00264	0.00358	CcSEcCtD
Clonidine—ADRA1B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00264	0.0101	CbGpPWpGaD
Clonidine—ADRA2A—Monoamine GPCRs—DRD2—nicotine dependence	0.00259	0.00994	CbGpPWpGaD
Clonidine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00253	0.00968	CbGpPWpGaD
Clonidine—Nausea—Varenicline—nicotine dependence	0.00251	0.00339	CcSEcCtD
Clonidine—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00239	0.00915	CbGpPWpGaD
Clonidine—ADRA1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00235	0.00899	CbGpPWpGaD
Clonidine—ADRA2B—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00233	0.00894	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00223	0.00856	CbGpPWpGaD
Clonidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00222	0.00849	CbGpPWpGaD
Clonidine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00219	0.00838	CbGpPWpGaD
Clonidine—ADRA2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00218	0.00836	CbGpPWpGaD
Clonidine—ADRA2C—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00218	0.00835	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00212	0.00812	CbGpPWpGaD
Clonidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00188	0.00719	CbGpPWpGaD
Clonidine—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00185	0.0071	CbGpPWpGaD
Clonidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0018	0.00688	CbGpPWpGaD
Clonidine—ADRA2A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00177	0.00678	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—CHRNB3—nicotine dependence	0.00171	0.00656	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—CHRNA6—nicotine dependence	0.00162	0.00622	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—TAS2R16—nicotine dependence	0.00156	0.006	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00153	0.00587	CbGpPWpGaD
Clonidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00152	0.00583	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00147	0.00563	CbGpPWpGaD
Clonidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00145	0.00555	CbGpPWpGaD
Clonidine—SLC22A4—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00143	0.00548	CbGpPWpGaD
Clonidine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00143	0.00548	CbGpPWpGaD
Clonidine—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00142	0.00545	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00141	0.00541	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00136	0.00523	CbGpPWpGaD
Clonidine—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00134	0.00515	CbGpPWpGaD
Clonidine—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00134	0.00514	CbGpPWpGaD
Clonidine—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00132	0.00507	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.00132	0.00506	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—TAS2R16—nicotine dependence	0.0013	0.00498	CbGpPWpGaD
Clonidine—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00127	0.00486	CbGpPWpGaD
Clonidine—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00125	0.00479	CbGpPWpGaD
Clonidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00117	0.0045	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—GABRA4—nicotine dependence	0.00117	0.0045	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00115	0.00442	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—CHRNB4—nicotine dependence	0.00112	0.00431	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00111	0.00426	CbGpPWpGaD
Clonidine—SLC22A3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00108	0.00413	CbGpPWpGaD
Clonidine—SLC22A5—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00108	0.00412	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00107	0.00411	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—CHRNA5—nicotine dependence	0.00105	0.00401	CbGpPWpGaD
Clonidine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00101	0.00388	CbGpPWpGaD
Clonidine—ADRA1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00101	0.00387	CbGpPWpGaD
Clonidine—ADRA2B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000984	0.00377	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000979	0.00375	CbGpPWpGaD
Clonidine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000954	0.00366	CbGpPWpGaD
Clonidine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000941	0.00361	CbGpPWpGaD
Clonidine—ADRA2C—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000919	0.00352	CbGpPWpGaD
Clonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000913	0.0035	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000889	0.00341	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000884	0.00339	CbGpPWpGaD
Clonidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000866	0.00332	CbGpPWpGaD
Clonidine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000858	0.00329	CbGpPWpGaD
Clonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000853	0.00327	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—CHRNA3—nicotine dependence	0.000852	0.00327	CbGpPWpGaD
Clonidine—SLC6A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00084	0.00322	CbGpPWpGaD
Clonidine—ADRA1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000839	0.00322	CbGpPWpGaD
Clonidine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000808	0.0031	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.000803	0.00308	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000798	0.00306	CbGpPWpGaD
Clonidine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000797	0.00305	CbGpPWpGaD
Clonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000782	0.003	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.00075	0.00288	CbGpPWpGaD
Clonidine—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000746	0.00286	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000746	0.00286	CbGpPWpGaD
Clonidine—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000745	0.00286	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000734	0.00281	CbGpPWpGaD
Clonidine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000731	0.0028	CbGpPWpGaD
Clonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00073	0.0028	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000725	0.00278	CbGpPWpGaD
Clonidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000719	0.00276	CbGpPWpGaD
Clonidine—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.000711	0.00273	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—FGD1—nicotine dependence	0.000694	0.00266	CbGpPWpGaD
Clonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000693	0.00265	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.000681	0.00261	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000677	0.0026	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000666	0.00255	CbGpPWpGaD
Clonidine—ADRA2C—G alpha (i) signalling events—DRD2—nicotine dependence	0.000664	0.00255	CbGpPWpGaD
Clonidine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000662	0.00254	CbGpPWpGaD
Clonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00066	0.00253	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—OPRM1—nicotine dependence	0.00066	0.00253	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000652	0.0025	CbGpPWpGaD
Clonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000639	0.00245	CbGpPWpGaD
Clonidine—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000631	0.00242	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.00063	0.00241	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000626	0.0024	CbGpPWpGaD
Clonidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000626	0.0024	CbGpPWpGaD
Clonidine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000624	0.00239	CbGpPWpGaD
Clonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000616	0.00236	CbGpPWpGaD
Clonidine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000615	0.00236	CbGpPWpGaD
Clonidine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000607	0.00232	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000606	0.00232	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000596	0.00228	CbGpPWpGaD
Clonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000593	0.00227	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000592	0.00227	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000585	0.00224	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000576	0.00221	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.000569	0.00218	CbGpPWpGaD
Clonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000565	0.00217	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000556	0.00213	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00055	0.00211	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000547	0.0021	CbGpPWpGaD
Clonidine—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.00054	0.00207	CbGpPWpGaD
Clonidine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000539	0.00207	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.000531	0.00204	CbGpPWpGaD
Clonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000528	0.00202	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000523	0.002	CbGpPWpGaD
Clonidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00052	0.00199	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000512	0.00196	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—CYP2A7—nicotine dependence	0.000505	0.00194	CbGpPWpGaD
Clonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000501	0.00192	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000486	0.00186	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.000477	0.00183	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000475	0.00182	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000474	0.00182	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000465	0.00178	CbGpPWpGaD
Clonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000462	0.00177	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000452	0.00173	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.000432	0.00165	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	0.000431	0.00165	CbGpPWpGaD
Clonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000429	0.00164	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000428	0.00164	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	0.000402	0.00154	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	0.0004	0.00153	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.000396	0.00152	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000394	0.00151	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000373	0.00143	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	0.000372	0.00143	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00037	0.00142	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000352	0.00135	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.00035	0.00134	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000339	0.0013	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000337	0.00129	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	0.000336	0.00129	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000329	0.00126	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000327	0.00125	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000325	0.00125	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000314	0.0012	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	0.000314	0.0012	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000309	0.00119	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	0.000309	0.00118	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—CYP2A7—nicotine dependence	0.000308	0.00118	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000306	0.00117	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000297	0.00114	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—CYP2A7—nicotine dependence	0.000295	0.00113	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	0.000285	0.00109	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000281	0.00108	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	0.000277	0.00106	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000275	0.00105	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	0.000274	0.00105	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000273	0.00105	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	0.00027	0.00103	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000255	0.000978	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	0.000255	0.000977	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	0.00025	0.00096	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	0.00025	0.000956	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	0.000245	0.000938	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	0.000243	0.000932	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000242	0.000929	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000232	0.000889	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	0.000232	0.000888	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000229	0.000879	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	0.000227	0.000871	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000225	0.000863	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	0.000224	0.000857	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	0.000222	0.000851	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	0.000221	0.000847	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000217	0.000831	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	0.000209	0.000801	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	0.000206	0.000791	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	0.000203	0.000778	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	0.000201	0.000768	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	0.0002	0.000766	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	0.000199	0.000761	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	0.000195	0.000749	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	0.000192	0.000737	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	0.000187	0.000718	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000185	0.000707	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	0.000184	0.000706	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	0.000181	0.000692	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	0.00018	0.000691	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000173	0.000664	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	0.000171	0.000654	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	0.000169	0.000646	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	0.000168	0.000642	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	0.000166	0.000636	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	0.000164	0.000627	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000163	0.000625	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	0.000159	0.000608	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	0.000152	0.000583	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	0.000147	0.000565	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	0.000145	0.000554	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000138	0.00053	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	0.000137	0.000525	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	0.000131	0.0005	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	0.000122	0.000467	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	0.00012	0.00046	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000107	0.000409	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	0.000107	0.000408	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	9.9e-05	0.000379	CbGpPWpGaD
